Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:46 AM
Ignite Modification Date:
2025-12-25 @ 3:46 AM
NCT ID:
NCT01903902
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 19 years
* Patients who are appropriate for percutaneous coronary intervention using drug-eluting balloon in native small coronary artery (vessel diameter ≥ 2.25 mm and ≤ 2.75 mm, lesion length \< 25 mm)
* Informed consent
Exclusion Criteria:
* Chronic total obstruction lesion
* Severe calcified lesion
* Left main coronary lesion
* Lesion having intravascular thrombus
* Shock status from any cause including cardiogenic shock
* Left ventricular ejection fraction \< 30%
* Need for coronary artery bypass surgery
* Allergic reaction for paclitaxel
* Severe allergic for contrast agent (Visipaque) or statin
* Pregnancy, breastfeeding or Expectation for pregnancy in women of childbearing age
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT01903902
Study Brief:
Protocol Section:
NCT01903902